SEIZURE CONTROL IN LOW-GRADE GLIOMA PATIENTS AFTER TREATMENT WITH TEMOZOLOMIDE

被引:0
|
作者
Koekkoek, Johan A. F. [1 ,2 ]
Reijneveld, Jaap C. [1 ]
Dirven, Linda [1 ]
Postma, Tjeerd J. [1 ]
Vos, Maaike J. [2 ]
Heimans, Jan J. [1 ]
Taphoorn, Martin J. B. [1 ,2 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[2] Med Ctr Haaglanden, The Hague, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:116 / 116
页数:1
相关论文
共 50 条
  • [1] Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
    Koekkoek, Johan A. F.
    Dirven, Linda
    Heimans, Jan J.
    Postma, Tjeerd J.
    Vos, Maaike J.
    Reijneveld, Jaap C.
    Taphoorn, Martin J. B.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 126 (02) : 347 - 354
  • [2] Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
    Johan A. F. Koekkoek
    Linda Dirven
    Jan J. Heimans
    Tjeerd J. Postma
    Maaike J. Vos
    Jaap C. Reijneveld
    Martin J. B. Taphoorn
    Journal of Neuro-Oncology, 2016, 126 : 347 - 354
  • [3] Temozolomide in the treatment of progressive low-grade glioma
    Saba, N
    Paes, V
    Galeana, J
    Pascalicchio, AP
    Cavalheiro, S
    NEURO-ONCOLOGY, 2004, 6 (04) : 465 - 465
  • [4] Temozolomide in the treatment of progressive low-grade glioma.
    Silva, NS
    Paes, V
    Galeana, J
    Pascalicchio, AP
    Galväo, C
    Cavalheiro, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 806S - 806S
  • [5] Temozolomide in pediatric low-grade glioma
    Khaw, Seong L.
    Coleman, Lee T.
    Downie, Peter A.
    Heath, John A.
    Ashley, David M.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (06) : 808 - 811
  • [6] Quality of life in low-grade glioma patients receiving temozolomide
    Liu, Raymond
    Solheim, Karla
    Polley, Mei-Yin
    Lamborn, Kathleen R.
    Page, Margaretta
    Fedoroff, Anne
    Rabbitt, Jane
    Butowski, Nicholas
    Prados, Michael
    Chang, Susan M.
    NEURO-ONCOLOGY, 2009, 11 (01) : 59 - 68
  • [7] Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide
    Koekkoek, Johan A. F.
    Dirven, Linda
    Heimans, Jan J.
    Postma, Tjeerd J.
    Vos, Maaike J.
    Reijneveld, Jaap C.
    Taphoorn, Martin J. B.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (04): : 366 - 373
  • [8] Temozolomide in children with progressive low-grade glioma
    Gururangan, Sridharan
    Fisher, Michael J.
    Allen, Jeffrey C.
    Herndon, James E., II
    Quinn, Jennifer A.
    Reardon, David A.
    Vredenburgh, James J.
    Desjardins, Annick
    Phillips, Peter C.
    Watral, Melody A.
    Krauser, Jeanne M.
    Friedman, Allan H.
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2007, 9 (02) : 161 - 168
  • [9] A Phase 2 Study of Temozolomide in the Treatment of Adult Patients With Supratentorial Low-Grade Glioma
    Wahl, M.
    Aicardi, J.
    Haas-Kogan, D. A.
    Butowski, N.
    Clarke, J.
    Prados, M.
    Phillips, J.
    Berger, M. S.
    Chang, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S109 - S109
  • [10] IMPACT OF TEMOZOLOMIDE CHEMOTHERAPY ON SEIZURE FREQUENCY IN PATIENTS WITH LOW-GRADE GLIOMAS
    Sherman, Jonathan
    Yeoh, Hian
    Pouratian, Nader
    Prevedello, Daniel
    Aregawi, Dawir
    Shaffrey, Mark
    Schiff, David
    NEURO-ONCOLOGY, 2008, 10 (05) : 832 - 832